Mouse models of experimental atherosclerosis

被引:0
|
作者
Jawién, J [1 ]
Nastalek, P [1 ]
Korbut, R [1 ]
机构
[1] Jagiellonian Univ, Sch Med, Chair Pharmacol, Dept Pharmacol, PL-31351 Krakow, Poland
来源
关键词
atherosclerosis; animal models; apoE-knockout mouse; LDL receptor - knockout mouse;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Since 1992 the mouse has become an excellent model for experimental atherosclerosis research. Until 1992, the diet - induced atherosclerosis mouse model has been used effectively, but the lesions tended to be small and were limited to early fatty-streak stage. This model was also criticized because of the toxicity and inflammatory responses due to the diet. In 1992 the first line of gene targeted animal models, namely apolipoprotein E - knockout mice was developed. Of the genetically engineered models, the apoE - deficient model is the only one that develops extensive atherosclerotic lesions on a chow diet. It is also the model in which the lesions have been characterized most thoroughly. The lesions develop into fibrous plaques; however, there is no evidence that plaque rupture occurs in this model. The LDL receptor - deficient model has elevated LDL levels, but no lesions, or only very small lesions, form on the chow diet, however, robust lesions do form on the western-type diet. The creation of apoE - knockout mice has changed the face of atherosclerosis research.
引用
收藏
页码:503 / 517
页数:15
相关论文
共 50 条
  • [41] Accelerated atherosclerosis in ApoE deficient lupus mouse models
    Ma, Zhongjie
    Choudhury, Arpita
    Kang, Sun-Ah
    Monestier, Marc
    Cohen, Philip L.
    Eisenberg, Robert A.
    CLINICAL IMMUNOLOGY, 2008, 127 (02) : 168 - 175
  • [42] Mouse models of atherosclerosis: a historical perspective and recent advances
    Yee Ting Lee
    Hiu Yu Lin
    Yin Wah Fiona Chan
    Ka Hou Christien Li
    Olivia Tsz Ling To
    Bryan P Yan
    Tong Liu
    Guangping Li
    Wing Tak Wong
    Wendy Keung
    Gary Tse
    Lipids in Health and Disease, 16
  • [43] Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis
    von Scheidt, Moritz
    Zhao, Yuqi
    Kurt, Zeyneb
    Pan, Calvin
    Zeng, Lingyao
    Yang, Xia
    Schunkert, Heribert
    Lusis, Aldons J.
    CELL METABOLISM, 2017, 25 (02) : 248 - 261
  • [44] Mouse models of atherosclerosis and their suitability for the study of myocardial infarction
    Pelin Golforoush
    Derek M. Yellon
    Sean M. Davidson
    Basic Research in Cardiology, 2020, 115
  • [45] Mouse models of C-pneumoniae infection and atherosclerosis
    Campbell, LA
    Blessing, E
    Rosenfeld, M
    Lin, TM
    Kuo, CC
    JOURNAL OF INFECTIOUS DISEASES, 2000, 181 : S508 - S513
  • [46] LCAT deficiency protects against atherosclerosis in mouse models
    Lambert, G
    Sakai, N
    Striker, GE
    Francois, TL
    Vaisman, BL
    Paigen, B
    Najib-Fruchart, J
    Csako, G
    Neufeld, EB
    Peterson, KM
    Brewer, HB
    Santamarina-Fojo, S
    CIRCULATION, 2000, 102 (18) : 46 - 46
  • [47] Mouse models of atherosclerosis: a historical perspective and recent advances
    Lee, Yee Ting
    Lin, Hiu Yu
    Chan, Yin Wah Fiona
    Li, Ka Hou Christien
    To, Olivia Tsz Ling
    Yan, Bryan P.
    Liu, Tong
    Li, Guangping
    Wong, Wing Tak
    Keung, Wendy
    Tse, Gary
    LIPIDS IN HEALTH AND DISEASE, 2017, 16
  • [48] NEW INSIGHTS INTO ATHEROSCLEROSIS FROM STUDIES WITH MOUSE MODELS
    SHIH, DM
    WELCH, C
    LUSIS, AJ
    MOLECULAR MEDICINE TODAY, 1995, 1 (08): : 364 - 372
  • [49] MOUSE APOLIPOPROTEIN-B - A USEFUL SCREENING TOOL FOR MOUSE MODELS OF ATHEROSCLEROSIS
    LEVINE, DM
    WILLIAMS, KJ
    CLINICAL CHEMISTRY, 1995, 41 (06) : S139 - S140
  • [50] PHARMACOLOGICAL ACTIVITY OF A SULFOBISANION IN MODELS OF EXPERIMENTAL DYSLIPOPROTEINEMIA AND ATHEROSCLEROSIS
    Okunevich, I. V.
    Khnychenko, L. K.
    Sapronov, N. S.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2013, 47 (07) : 374 - 377